Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-21-014051
Filing Date
2021-11-05
Accepted
2021-11-05 15:26:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1370188
2 GRAPHIC g143161g24f20.jpg GRAPHIC 107469
3 GRAPHIC g143161g60d63.jpg GRAPHIC 111650
  Complete submission text file 0000950123-21-014051.txt   1673325
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-04413 | Film No.: 211384272
SIC: 6770 Blank Checks